View in EDS HTML Full Text PDF Full Text

BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study.

Saved in:
Bibliographic Details
Title: BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study.
Authors: Rodriguez, Cesar1 (AUTHOR) cesar.rodriguez@mssm.edu, Rodriguez, Tulio2 (AUTHOR), Kentos, Alain3 (AUTHOR), Driessen, Christoph4 (AUTHOR), Sunami, Kazutaka5 (AUTHOR), Lesokhin, Alexander M.6 (AUTHOR), Yee, Andrew J.7 (AUTHOR), Minella, Alex C.8 (AUTHOR), Maraboina, Ravikanth9 (AUTHOR), Upreti, Vijay V.10 (AUTHOR), Zhou, Di10 (AUTHOR), Shabooti, Mohamed8 (AUTHOR), Stieglmaier, Julia11 (AUTHOR), Quach, Hang12 (AUTHOR)
Source: Leukemia & Lymphoma. Nov2025, Vol. 66 Issue 11, p2108-2117. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2025.2528115